142 related articles for article (PubMed ID: 37009089)
21. Combined intravitreal melphalan and intravenous/intra-arterial chemotherapy for retinoblastoma with vitreous seeds.
Lee JH; Han JW; Hahn SM; Lyu CJ; Kim DJ; Lee SC
Graefes Arch Clin Exp Ophthalmol; 2016 Feb; 254(2):391-4. PubMed ID: 26511530
[TBL] [Abstract][Full Text] [Related]
22. Safety and Efficacy of Intravitreal Chemotherapy (Melphalan) to Treat Vitreous Seeds in Retinoblastoma.
Yousef YA; Al Jboor M; Mohammad M; Mehyar M; Toro MD; Nazzal R; Alzureikat QH; Rejdak M; Elfalah M; Sultan I; Rejdak R; Al-Hussaini M; Al-Nawaiseh I
Front Pharmacol; 2021; 12():696787. PubMed ID: 34322023
[No Abstract] [Full Text] [Related]
23. Ocular toxicity of intravitreal melphalan for retinoblastoma in Chinese patients.
Xue K; Ren H; Meng F; Zhang R; Qian J
BMC Ophthalmol; 2019 Feb; 19(1):61. PubMed ID: 30808420
[TBL] [Abstract][Full Text] [Related]
24. Factors predictive of recurrence of retinal tumors, vitreous seeds, and subretinal seeds following chemoreduction for retinoblastoma.
Shields CL; Honavar SG; Shields JA; Demirci H; Meadows AT; Naduvilath TJ
Arch Ophthalmol; 2002 Apr; 120(4):460-4. PubMed ID: 11934319
[TBL] [Abstract][Full Text] [Related]
25. Secondary and tertiary intra-arterial chemotherapy for massive persistent or recurrent subretinal retinoblastoma seeds following previous chemotherapy exposure: long-term tumor control and globe salvage in 30 eyes.
Say EA; Iyer PG; Hasanreisoglu M; Lally SE; Jabbour P; Shields JA; Shields CL
J AAPOS; 2016 Aug; 20(4):337-42. PubMed ID: 27328850
[TBL] [Abstract][Full Text] [Related]
26. Intravitreal chemotherapy in retinoblastoma: expanded use beyond intravitreal seeds.
Abramson DH; Ji X; Francis JH; Catalanotti F; Brodie SE; Habib L
Br J Ophthalmol; 2019 Apr; 103(4):488-493. PubMed ID: 29875233
[TBL] [Abstract][Full Text] [Related]
27. Diffuse chorioretinal atrophy after a single standard low- dose intravitreal melphalan injection in a child with retinoblastoma: a case report.
Chao A; Kao LY; Liu L; Wang NK
BMC Ophthalmol; 2016 Mar; 16():27. PubMed ID: 26975871
[TBL] [Abstract][Full Text] [Related]
28. Precision Intravitreal Chemotherapy for Localized Vitreous Seeding of Retinoblastoma.
Yu MD; Dalvin LA; Welch RJ; Shields CL
Ocul Oncol Pathol; 2019 Jun; 5(4):284-289. PubMed ID: 31367592
[TBL] [Abstract][Full Text] [Related]
29. Intravitreal chemotherapy for vitreous disease in retinoblastoma revisited: from prohibition to conditional indications.
Munier FL; Gaillard MC; Balmer A; Soliman S; Podilsky G; Moulin AP; Beck-Popovic M
Br J Ophthalmol; 2012 Aug; 96(8):1078-83. PubMed ID: 22694968
[TBL] [Abstract][Full Text] [Related]
30. Intra-arterial chemotherapy for retinoblastoma: First Indian report.
Rishi P; Sharma T; Koundanya V; Bansal N; Saravanan M; Ravikumar R; Ramamurthy S
Indian J Ophthalmol; 2015 Apr; 63(4):331-4. PubMed ID: 26044473
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and toxicity of second-course ophthalmic artery chemosurgery for retinoblastoma.
Francis JH; Abramson DH; Gobin YP; Marr BP; Tendler I; Brodie SE; Dunkel IJ
Ophthalmology; 2015 May; 122(5):1016-22. PubMed ID: 25616769
[TBL] [Abstract][Full Text] [Related]
32. Local and systemic toxicity of intravitreal melphalan for vitreous seeding in retinoblastoma: a preclinical and clinical study.
Francis JH; Schaiquevich P; Buitrago E; Del Sole MJ; Zapata G; Croxatto JO; Marr BP; Brodie SE; Berra A; Chantada GL; Abramson DH
Ophthalmology; 2014 Sep; 121(9):1810-7. PubMed ID: 24819859
[TBL] [Abstract][Full Text] [Related]
33. Retinoblastoma Control With Primary Intra-arterial Chemotherapy: Outcomes Before and During the Intravitreal Chemotherapy Era.
Shields CL; Alset AE; Say EA; Caywood E; Jabbour P; Shields JA
J Pediatr Ophthalmol Strabismus; 2016 Sep; 53(5):275-84. PubMed ID: 27486728
[TBL] [Abstract][Full Text] [Related]
34. Pushing the limit: Globe salvage of Group D retinoblastoma with severe vitreous seeding with intra-arterial chemotherapy and 15 cycles of intravitreal chemotherapy.
Greig EC; Rabiee R; Afshar AR
Am J Ophthalmol Case Rep; 2024 Mar; 33():101987. PubMed ID: 38283770
[TBL] [Abstract][Full Text] [Related]
35. Management of Recurrence in Retinoblastoma Based on the Source of Tumor Cells.
Thaker SK; Shah PK; Das A; Maitra P
Middle East Afr J Ophthalmol; 2023; 30(1):24-30. PubMed ID: 38435107
[TBL] [Abstract][Full Text] [Related]
36. Intravitreal injection of melphalan for intraocular retinoblastoma.
Suzuki S; Aihara Y; Fujiwara M; Sano S; Kaneko A
Jpn J Ophthalmol; 2015 May; 59(3):164-72. PubMed ID: 25808017
[TBL] [Abstract][Full Text] [Related]
37. Ocular Survival Following Intravitreal Melphalan as Adjuvant Treatment for Vitreous Retinoblastoma Seeding.
Alahmadi G; Maktabi AMY; Sesma G; Almesfer S
Clin Ophthalmol; 2023; 17():1789-1800. PubMed ID: 37377999
[TBL] [Abstract][Full Text] [Related]
38. Efficacy and Toxicity of Intravitreous Chemotherapy for Retinoblastoma: Four-Year Experience.
Francis JH; Brodie SE; Marr B; Zabor EC; Mondesire-Crump I; Abramson DH
Ophthalmology; 2017 Apr; 124(4):488-495. PubMed ID: 28089679
[TBL] [Abstract][Full Text] [Related]
39. [Short-term efficacy of intravitreal injection of melphalan for refractory vitreous seeding from retinoblastoma].
Xue K; Ren H; Zhang R; Yuan YF; Qian J
Zhonghua Yan Ke Za Zhi; 2017 Aug; 53(8):570-574. PubMed ID: 28851196
[No Abstract] [Full Text] [Related]
40. Combined intra-arterial chemotherapy and intravitreal melphalan for the treatment of advanced unilateral retinoblastoma.
Liang TY; Zhu XY; Hua XM; Ji XD; Zhao PQ
Int J Ophthalmol; 2020; 13(2):257-262. PubMed ID: 32090035
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
